Patrick Donnelly
Stock Analyst at Citigroup
(5.00)
# 13
Out of 4,842 analysts
329
Total ratings
49.14%
Success rate
152.8%
Average return
Main Sectors:
Stocks Rated by Patrick Donnelly
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BRKR Bruker | Downgrades: Neutral | $50 → $40 | $36.96 | +8.23% | 16 | May 22, 2025 | |
| BIO Bio-Rad Laboratories | Maintains: Buy | $400 → $350 | $229.15 | +52.74% | 15 | May 2, 2025 | |
| BIO.B Bio-Rad Laboratories | Maintains: Buy | $400 → $350 | $230.22 | +52.03% | 15 | May 2, 2025 | |
| ILMN Illumina | Maintains: Neutral | $90 → $85 | $84.43 | +0.68% | 16 | Apr 7, 2025 | |
| ICLR ICON Public Limited Company | Maintains: Buy | $290 → $215 | $130.84 | +64.32% | 9 | Apr 7, 2025 | |
| MTD Mettler-Toledo International | Upgrades: Buy | $1,400 | $1,157.50 | +20.95% | 13 | Apr 7, 2025 | |
| TXG 10x Genomics | Maintains: Buy | $20 → $15 | $8.86 | +69.30% | 12 | Mar 4, 2025 | |
| AVTR Avantor | Maintains: Neutral | $22 → $18 | $13.03 | +38.14% | 8 | Mar 4, 2025 | |
| TECH Bio-Techne | Maintains: Neutral | $80 → $70 | $47.93 | +46.05% | 11 | Mar 4, 2025 | |
| HOLX Hologic | Maintains: Neutral | $80 → $70 | $63.71 | +9.87% | 14 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $225 → $210 | $138.78 | +51.32% | 10 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $650 → $570 | $402.13 | +41.75% | 19 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $185 | $171.38 | +7.95% | 11 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $155 → $175 | $136.25 | +28.44% | 20 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $285 → $265 | $189.01 | +40.20% | 12 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $30 → $23 | $4.18 | +450.24% | 4 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $44 → $50 | $31.70 | +57.73% | 4 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $20 | $12.20 | +63.93% | 3 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $75 | $58.08 | +29.13% | 13 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $165 | $110.88 | +48.81% | 26 | Aug 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $45 | $38.19 | +17.83% | 9 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $28 | $23.19 | +20.74% | 4 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $135 → $145 | $91.34 | +58.75% | 1 | Jul 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $64 → $62 | $44.38 | +39.25% | 13 | Feb 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $265 → $300 | $354.59 | -15.40% | 24 | Dec 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $9 | $2.78 | +224.32% | 6 | Dec 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3.75 → $2.75 | $1.64 | +67.68% | 4 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $250 → $260 | $247.03 | +5.25% | 11 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $6 | $4.70 | +27.66% | 4 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $28 → $32 | $4.33 | +639.03% | 2 | Nov 30, 2018 |
Bruker
May 22, 2025
Downgrades: Neutral
Price Target: $50 → $40
Current: $36.96
Upside: +8.23%
Bio-Rad Laboratories
May 2, 2025
Maintains: Buy
Price Target: $400 → $350
Current: $229.15
Upside: +52.74%
Bio-Rad Laboratories
May 2, 2025
Maintains: Buy
Price Target: $400 → $350
Current: $230.22
Upside: +52.03%
Illumina
Apr 7, 2025
Maintains: Neutral
Price Target: $90 → $85
Current: $84.43
Upside: +0.68%
ICON Public Limited Company
Apr 7, 2025
Maintains: Buy
Price Target: $290 → $215
Current: $130.84
Upside: +64.32%
Mettler-Toledo International
Apr 7, 2025
Upgrades: Buy
Price Target: $1,400
Current: $1,157.50
Upside: +20.95%
10x Genomics
Mar 4, 2025
Maintains: Buy
Price Target: $20 → $15
Current: $8.86
Upside: +69.30%
Avantor
Mar 4, 2025
Maintains: Neutral
Price Target: $22 → $18
Current: $13.03
Upside: +38.14%
Bio-Techne
Mar 4, 2025
Maintains: Neutral
Price Target: $80 → $70
Current: $47.93
Upside: +46.05%
Hologic
Mar 4, 2025
Maintains: Neutral
Price Target: $80 → $70
Current: $63.71
Upside: +9.87%
Mar 4, 2025
Maintains: Neutral
Price Target: $225 → $210
Current: $138.78
Upside: +51.32%
Mar 4, 2025
Maintains: Neutral
Price Target: $650 → $570
Current: $402.13
Upside: +41.75%
Mar 4, 2025
Downgrades: Neutral
Price Target: $185
Current: $171.38
Upside: +7.95%
Mar 4, 2025
Upgrades: Neutral
Price Target: $155 → $175
Current: $136.25
Upside: +28.44%
Jan 30, 2025
Maintains: Buy
Price Target: $285 → $265
Current: $189.01
Upside: +40.20%
Dec 11, 2024
Downgrades: Neutral
Price Target: $30 → $23
Current: $4.18
Upside: +450.24%
Dec 11, 2024
Upgrades: Buy
Price Target: $44 → $50
Current: $31.70
Upside: +57.73%
Nov 6, 2024
Maintains: Buy
Price Target: $18 → $20
Current: $12.20
Upside: +63.93%
Nov 6, 2024
Maintains: Buy
Price Target: $80 → $75
Current: $58.08
Upside: +29.13%
Aug 22, 2024
Maintains: Buy
Price Target: $150 → $165
Current: $110.88
Upside: +48.81%
Aug 8, 2024
Maintains: Buy
Price Target: $40 → $45
Current: $38.19
Upside: +17.83%
Aug 7, 2024
Maintains: Buy
Price Target: $30 → $28
Current: $23.19
Upside: +20.74%
Jul 30, 2024
Maintains: Buy
Price Target: $135 → $145
Current: $91.34
Upside: +58.75%
Feb 8, 2024
Maintains: Buy
Price Target: $64 → $62
Current: $44.38
Upside: +39.25%
Dec 11, 2023
Maintains: Neutral
Price Target: $265 → $300
Current: $354.59
Upside: -15.40%
Dec 11, 2023
Maintains: Buy
Price Target: $7 → $9
Current: $2.78
Upside: +224.32%
Aug 10, 2023
Maintains: Neutral
Price Target: $3.75 → $2.75
Current: $1.64
Upside: +67.68%
Feb 17, 2023
Maintains: Neutral
Price Target: $250 → $260
Current: $247.03
Upside: +5.25%
Nov 3, 2022
Maintains: Buy
Price Target: $8 → $6
Current: $4.70
Upside: +27.66%
Nov 30, 2018
Upgrades: Neutral
Price Target: $28 → $32
Current: $4.33
Upside: +639.03%